Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-25-048696

Chief Financial Officer bought 33,333 shares at $2.25 ($74,946)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Graham Juan Chief Financial Officer 2025-03-28 Purchase +33,333 $2.25 $74,946 35,354 D
Open-market purchases · 33,333 sh · avg $2.25 · $74,946
Loading xslF345X05/ownership.xml…